Insider · CIK 0001581954

Higgons John Duncan

CIK 0001581954 Name as filed on the most recent filing

Filed as Higgons John Duncan (36)

39 transaction lines · from 36 filings · filed 2014-01-23 to 2021-04-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

39 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-04-15 S, Open-market sale Jounce Therapeutics, Inc.JNCE 2,000, disposed Open Form 4 filing 0001640455-21-000074
2021-03-15 S, Open-market sale Jounce Therapeutics, Inc.JNCE 2,560, disposed Open Form 4 filing 0001640455-21-000070
2021-02-16 S, Open-market sale Jounce Therapeutics, Inc.JNCE 2,356, disposed Open Form 4 filing 0001640455-21-000040
2021-01-21 S, Open-market sale Jounce Therapeutics, Inc.JNCE 2,222, disposed Open Form 4 filing 0001640455-21-000017
2021-01-20 S, Open-market sale Jounce Therapeutics, Inc.JNCE 18,000, disposed Open Form 4 filing 0001640455-21-000017
2020-01-06 S, Open-market sale Jounce Therapeutics, Inc.JNCE 12,165, disposed Open Form 4 filing 0001640455-20-000002
2017-02-01 P, Open-market purchase Jounce Therapeutics, Inc.JNCE 107,200, acquired Open Form 4 filing 0001104659-17-006178
2015-12-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,001,800, disposed Open Form 4 filing 0001209191-15-085756
2015-11-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,230,200, disposed Open Form 4 filing 0001209191-15-080927
2015-10-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,420,800, disposed Open Form 4 filing 0001209191-15-076128
2015-09-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,822,200, disposed Open Form 4 filing 0001209191-15-071254
2015-08-17 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,844,800, disposed Open Form 4 filing 0001209191-15-066876
2015-07-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 2,280,400, disposed Open Form 4 filing 0001209191-15-061528
2015-06-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 736,610, disposed Open Form 4 filing 0001209191-15-053911
2015-05-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 837,305, disposed Open Form 4 filing 0001209191-15-043985
2015-04-15 S, Open-market sale Agios Pharmaceuticals IncAGIO 655,272, disposed Open Form 4 filing 0001209191-15-035056
2015-03-16 S, Open-market sale Agios Pharmaceuticals IncAGIO 743,680, disposed Open Form 4 filing 0001209191-15-027549
2015-01-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,320,960, disposed Open Form 4 filing 0001209191-15-002388
2015-01-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,320,960, disposed Open Form 4 filing 0001209191-15-002384
2014-12-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,164,360, disposed Open Form 4 filing 0001209191-14-072460
2014-11-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 1,062,230, disposed Open Form 4 filing 0001209191-14-066361
2014-10-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 780,910, disposed Open Form 4 filing 0001209191-14-061808
2014-09-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 601,900, disposed Open Form 4 filing 0001209191-14-055715
2014-08-26 S, Open-market sale Agios Pharmaceuticals IncAGIO 225,250, disposed Open Form 4 filing 0001209191-14-054841
2014-08-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 273,630, disposed Open Form 4 filing 0001209191-14-050727
2014-07-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 558,240, disposed Open Form 4 filing 0001209191-14-045507
2014-06-13 S, Open-market sale Agios Pharmaceuticals IncAGIO 226,350, disposed Open Form 4 filing 0001209191-14-041697
2014-06-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 129,537, disposed Open Form 4 filing 0001209191-14-039124
2014-06-02 S, Open-market sale Agios Pharmaceuticals IncAGIO 111,771, disposed Open Form 4 filing 0001209191-14-039124
2014-05-06 S, Open-market sale Agios Pharmaceuticals IncAGIO 228,650, disposed Open Form 4 filing 0001209191-14-031954
2014-05-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 296,730, disposed Open Form 4 filing 0001209191-14-031224
2014-04-07 S, Open-market sale Agios Pharmaceuticals IncAGIO 135,510, disposed Open Form 4 filing 0001209191-14-026530
2014-04-01 S, Open-market sale Agios Pharmaceuticals IncAGIO 456,960, disposed Open Form 4 filing 0001209191-14-025627
2014-03-07 S, Open-market sale Agios Pharmaceuticals IncAGIO 405,900, disposed Open Form 4 filing 0001209191-14-018464
2014-03-06 S, Open-market sale Agios Pharmaceuticals IncAGIO 200,659, disposed Open Form 4 filing 0001209191-14-018464
2014-03-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 238,832, disposed Open Form 4 filing 0001209191-14-016819
2014-02-18 S, Open-market sale Agios Pharmaceuticals IncAGIO 82,531, disposed Open Form 4 filing 0001209191-14-012589
2014-02-03 S, Open-market sale Agios Pharmaceuticals IncAGIO 207,728, disposed Open Form 4 filing 0001209191-14-007368
2014-01-21 S, Open-market sale Agios Pharmaceuticals IncAGIO 416,530, disposed Open Form 4 filing 0001209191-14-004638

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 38
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Higgons John Duncan, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001581954

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.